Concentration-Response Relationship For Ustekinumab, N. Van Den Berghe

Concentration–response relationship for ustekinumab, N. Van den Berghe

British Journal of Dermatology

Pharmacodynamics - Part 2: Dose-response Relationship

AMBOSS: Medical Knowledge Distilled

Ustekinumab as the New Frontline Treatment

Dose-Response Relationship - Pharmacodynamics Lecture | Potency, Efficacy, Therapeutic Index etc

Dose response relationship pharmacology

Nicholas Pulliam, PhD

Ustekinumab shows potential for the treatment of SLE | Ronald van Vollenhoven

Medicine Matters rheumatology

Pharmacodynamics

Dose response relationship

Tips & Tricks by AMB

September 2020 IBD Club | Combination therapy with Vedolizumab or Ustekinumab

Treatment persistence of ustekinumab in Crohn’s disease - Video abstract [ID 310076]

Dove Medical Press

IBDClub |June 2023| Vedolizumab vs. Ustekinumab in Crohn's Disease

The PAUSE Study – A Clinical Trial for People with Psoriasis

ImmuneTolerance

Stelara (ustekinumab) Injection

STELARA® Phase 3 Data - Treatment for Ulcerative Colitis

HPR

Using neuroimaging to track inflammation in Alzheimer’s disease

Quantifying alpha-synuclein in the skin for the diagnosis of DLB: insights from Synuclein-One

M3I MoDRN Toxicology Dose Response

Cytokinic and metagenomic study of acute exanthemas in adult patients, O. Deschamps et al.

British Journal of Dermatology

BE BRIGHT 3-year responder analysis, B. Strober et al.

British Journal of Dermatology